Previous Page  46 / 101 Next Page
Information
Show Menu
Previous Page 46 / 101 Next Page
Page Background

Biophysics in the Understanding, Diagnosis, and Treatment of Infectious Diseases Speaker Abstracts

41

Structure-based Discovery of Novel DNA Gyrase B Inhibitors

Matjaz Brvar

1

, Andrej Perdih

1

, Tihomir Tomasic

2

, Nace Zidar

2

, Lucija PeterlinMasic

2

, Janez

Ilas

2

, Danijel Kikelj

2

, Marko Anderluh

2

,

Tom Solmajer

1

.

1

National Institute of Chemistry, Ljubljana, Slovenia,

2

Faculty of Pharmacy University of

Ljubljana, Ljubljana, Slovenia.

The emergence of bacterial resistance to most of the clinically used antibiotics and the urgent

need for the discovery of potent antibacterials with broad spectrum of efficacy and improved

safety profile has revived the research in this field [1]. One of the well established targets is the

DNA gyrase B[2], a topoisomerase with an ATP-ase activity. In our ongoing effort to identify

low molecular weight inhibitors of DNA gyrase B we used structure-based design approach.

Starting from the available structural information[3] we identified a series of novel indolinone-2-

ones,[4] 2-2-amino-4-(2,4 dihydroxyphenyl)thiazoles,[5] and more recently, 4’-methyl-N2-

phenyl-[4,5’-bithiazole]-2,2’-diamine inhibitors of gyrase B with a low micromolar inhibitory

activity[6]. These inhibitors were subsequently extensively characterized by various biophysical

techniques (differential scanning fluorimetry, surface plasmon resonance and microscale

thermophoresis). Further studies resulted in discovery of 4,5-dibromopyrrolamides, indolamides

and 4,5,6,7-tetrahydrobenzo[1,2-d]thiazoles[7] as ATP competitive DNA gyrase B inhibitors.

Details of a nanomolar inhibitor 4-(4,5-dibromo-pyrrole-2-carboxamido)benzamide binding

mode were revealed by high-resolution crystal structure of the complex with E. coli DNA gyrase

B.[8] .References[1] E.D. Brown, G. D. Wright, Chem. Rev. 2005, 105, 759.[2] M. Oblak, M.

Kotnik, T. Solmajer, Curr. med. chem., 2007, 14, 2033.[3] R.J. Lewis, D.B. Wigley et al.,

EMBO J. 1996, 15, 1412.[4] M. Oblak, T. Solmajer et al., Bioorg & Med. Chem. Lett. 2005, 15

5207.[5] M. Brvar, T. Solmajer et al., Bioorg. Med. Chem. Lett. 2010, 20, 958.[6] M. Brvar,T.

Solmajer et al., J. Med. Chem. 2012, 55, 6413.[7] T. Tomasic, N., T. Solmajer et al., – J.

Med.Chem.2015, Articles ASAP .[8] N. Zidar, T. Solmajer et al., - J. Med. Chem.2015, Articles

ASAP